Does OLARATUMAB Cause Neoplasm progression? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Neoplasm progression have been filed in association with OLARATUMAB. This represents 3.2% of all adverse event reports for OLARATUMAB.
18
Reports of Neoplasm progression with OLARATUMAB
3.2%
of all OLARATUMAB reports
4
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm progression From OLARATUMAB?
Of the 18 reports, 4 (22.2%) resulted in death, and 10 (55.6%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLARATUMAB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does OLARATUMAB Cause?
Off label use (124)
Neutropenia (66)
Infusion related reaction (64)
Febrile neutropenia (57)
Drug ineffective (49)
Death (44)
Malignant neoplasm progression (43)
Product use in unapproved indication (40)
Disease progression (33)
Anaphylactic reaction (29)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which OLARATUMAB Alternatives Have Lower Neoplasm progression Risk?
OLARATUMAB vs OLECLUMAB
OLARATUMAB vs OLIVE OIL\SOYBEAN OIL
OLARATUMAB vs OLMESARTAN
OLARATUMAB vs OLMESARTAN MEDOXOMIL
OLARATUMAB vs OLMETEC